Bayer: Science for a Better Life

13 October 2020,
DoubleTree - Tower of London

Headline Partner

Bayer: Science for a Better Life

At Bayer, we know that a step-change in design and delivery is needed to meet the challenge of providing sustainable healthcare, now and into the future.

The burden of managing cardiovascular risk has rightly been identified as one of the key healthcare challenges that will need to be addressed over the coming decades.

Bayer has a proven heritage in this area. We not only create innovative medicines, but also work in partnership across a dynamic healthcare environment to design and most importantly implement new models of care for patients.

For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help to make a difference to people’s lives, not only in cardiovascular disease, but also oncology, women’s health and ophthalmology.

The solutions we create together today will advance life tomorrow, and help people and the planet to thrive.

By continuing to use the site you agree to our cookies policy. Accept